Shari Annes | Investor Relations |
Brian Hahn | Chief Financial Officer |
Rachel King | Chief Executive Officer |
Helen Thackray | Senior Vice-President, Clinical Development and Chief Medical Officer |
Yatin Suneja | SunTrust Robinson Humphrey |
Prakhar Verma | Stifel Financial Corp. |
Good morning. And thank you all for joining GlycoMimetics Third Quarter 2017 Conference Call. At this time, all participants are in a listen-only mode.
Following management's remarks, we will hold a brief question-and-answer session. And at that time, the lines will be opened for you.